Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Unemo

Showing results (351-360 of 438) with videos related to

Pageof 44
Sort By:
Plos One|April 14, 2017
Prevalence of macrolide and fluoroquinolone resistance-mediating mutations in Mycoplasma genitalium in five cities in Russia and EstoniaElena Shipitsyna, Tatiana Rumyantseva, Daniel Golparian, et al.
The Lancet. Microbe|June 6, 2022
Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: a genomic surveillance studyLeonor Sánchez-Busó, Michelle J Cole, Gianfranco Spiteri, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2013
Target gene sequencing to define the susceptibility of Neisseria meningitidis to ciprofloxacinEva Hong, Sara Thulin Hedberg, Raquel Abad, et al.
Frontiers in Microbiology|March 13, 2023
<i>Mycoplasma genitalium</i> prevalence, antimicrobial resistance-associated mutations, and coinfections with non-viral sexually transmitted infections in high-risk populations in Guatemala, Malta, Morocco, Peru and South Africa, 2019-2021Elena Shipitsyna, Ranmini Kularatne, Daniel Golparian, et al.
Pathogens and Disease|September 12, 2013
Plasmid deficiency in urogenital isolates of Chlamydia trachomatis reduces infectivity and virulence in a mouse modelIra M Sigar, Justin H Schripsema, Yibing Wang, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 29, 2026
Extensively drug-resistant (XDR) <i>Neisseria gonorrhoeae</i> cured with ceftriaxone 2 g intravenous monotherapy in Croatia, March 2026Tajana Juzbašić, Tatjana Nemeth Blažić, Nilia Volarević, et al.
Plos One|March 2, 2022
First characterisation of antimicrobial susceptibility and resistance of Neisseria gonorrhoeae isolates in Qatar, 2017-2020Muna Al-Maslamani, Emad Bashier Ibrahim Elmagboul, Aslam Puthiyottil, et al.
The Lancet. Microbe|September 27, 2025
WHO global gonococcal antimicrobial surveillance programmes, 2019-22: a retrospective observational studyMagnus Unemo, Monica M Lahra, Michelle J Cole, et al.
NPJ Vaccines|June 8, 2026
Pre-clinical efficacy of a candidate outer membrane vesicle gonococcal vaccine in comparison with 4CMenBPaula Freixeiro, Lisa A Lewis, Leonor Sánchez-Busó, et al.
The Lancet. Microbe|May 11, 2022
WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017-18: a retrospective observational studyMagnus Unemo, Monica M Lahra, Martina Escher, et al.
Pageof 44

Showing results (351-360 of 438) with videos related to

Sort By:
Pageof 44
Plos One|April 14, 2017
Prevalence of macrolide and fluoroquinolone resistance-mediating mutations in Mycoplasma genitalium in five cities in Russia and EstoniaElena Shipitsyna, Tatiana Rumyantseva, Daniel Golparian, et al.
The Lancet. Microbe|June 6, 2022
Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: a genomic surveillance studyLeonor Sánchez-Busó, Michelle J Cole, Gianfranco Spiteri, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2013
Target gene sequencing to define the susceptibility of Neisseria meningitidis to ciprofloxacinEva Hong, Sara Thulin Hedberg, Raquel Abad, et al.
Frontiers in Microbiology|March 13, 2023
<i>Mycoplasma genitalium</i> prevalence, antimicrobial resistance-associated mutations, and coinfections with non-viral sexually transmitted infections in high-risk populations in Guatemala, Malta, Morocco, Peru and South Africa, 2019-2021Elena Shipitsyna, Ranmini Kularatne, Daniel Golparian, et al.
Pathogens and Disease|September 12, 2013
Plasmid deficiency in urogenital isolates of Chlamydia trachomatis reduces infectivity and virulence in a mouse modelIra M Sigar, Justin H Schripsema, Yibing Wang, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 29, 2026
Extensively drug-resistant (XDR) <i>Neisseria gonorrhoeae</i> cured with ceftriaxone 2 g intravenous monotherapy in Croatia, March 2026Tajana Juzbašić, Tatjana Nemeth Blažić, Nilia Volarević, et al.
Plos One|March 2, 2022
First characterisation of antimicrobial susceptibility and resistance of Neisseria gonorrhoeae isolates in Qatar, 2017-2020Muna Al-Maslamani, Emad Bashier Ibrahim Elmagboul, Aslam Puthiyottil, et al.
The Lancet. Microbe|September 27, 2025
WHO global gonococcal antimicrobial surveillance programmes, 2019-22: a retrospective observational studyMagnus Unemo, Monica M Lahra, Michelle J Cole, et al.
NPJ Vaccines|June 8, 2026
Pre-clinical efficacy of a candidate outer membrane vesicle gonococcal vaccine in comparison with 4CMenBPaula Freixeiro, Lisa A Lewis, Leonor Sánchez-Busó, et al.
The Lancet. Microbe|May 11, 2022
WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017-18: a retrospective observational studyMagnus Unemo, Monica M Lahra, Martina Escher, et al.
Pageof 44